These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24355196)

  • 1. High-stage urachal adenocarcinoma can be associated with microsatellite instability and KRAS mutations.
    Sirintrapun SJ; Ward M; Woo J; Cimic A
    Hum Pathol; 2014 Feb; 45(2):327-30. PubMed ID: 24355196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma.
    Cornejo KM; Cosar EF; Paner GP; Yang P; Tomaszewicz K; Meng X; Mehta V; Sirintrapun SJ; Barkan GA; Hutchinson L
    Int J Surg Pathol; 2020 Feb; 28(1):51-59. PubMed ID: 31496327
    [No Abstract]   [Full Text] [Related]  

  • 3. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
    Preto A; Figueiredo J; Velho S; Ribeiro AS; Soares P; Oliveira C; Seruca R
    J Pathol; 2008 Feb; 214(3):320-7. PubMed ID: 18098337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion.
    Stewart CJ; Amanuel B; Grieu F; Carrello A; Iacopetta B
    J Clin Pathol; 2010 Jul; 63(7):604-8. PubMed ID: 20591910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
    Reis H; van der Vos KE; Niedworok C; Herold T; Módos O; Szendrői A; Hager T; Ingenwerth M; Vis DJ; Behrendt MA; de Jong J; van der Heijden MS; Peyronnet B; Mathieu R; Wiesweg M; Ablat J; Okon K; Tolkach Y; Keresztes D; Nagy N; Bremmer F; Gaisa NT; Chlosta P; Kriegsmann J; Kovalszky I; Timar J; Kristiansen G; Radzun HJ; Knüchel R; Schuler M; Black PC; Rübben H; Hadaschik BA; Schmid KW; van Rhijn BWG; Nyirády P; Szarvas T
    Int J Cancer; 2018 Oct; 143(7):1764-1773. PubMed ID: 29672836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
    Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Clin Cancer Res; 2013 Jun; 19(12):3285-96. PubMed ID: 23633456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix.
    Dimmler A; Geddert H; Faller G
    Pathol Res Pract; 2014 May; 210(5):274-8. PubMed ID: 24560515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?
    Ondrejka SL; Schaeffer DF; Jakubowski MA; Owen DA; Bronner MP
    Am J Surg Pathol; 2011 Sep; 35(9):1327-30. PubMed ID: 21836482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
    Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
    Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.
    Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J
    Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
    Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
    Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and molecular profiles of microsatellite unstable Barrett Esophagus-associated adenocarcinoma.
    Farris AB; Demicco EG; Le LP; Finberg KE; Miller J; Mandal R; Fukuoka J; Cohen C; Gaissert HA; Zukerberg LR; Lauwers GY; Iafrate AJ; Mino-Kenudson M
    Am J Surg Pathol; 2011 May; 35(5):647-55. PubMed ID: 21422910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
    Paner GP; Lopez-Beltran A; Sirohi D; Amin MB
    Adv Anat Pathol; 2016 Mar; 23(2):71-83. PubMed ID: 26849813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic profiling of glandular bladder tumours.
    Maurer A; Ortiz-Bruechle N; Guricova K; Rose M; Morsch R; Garczyk S; Stöhr R; Bertz S; Golz R; Reis H; Bremmer F; Zimpfer A; Siegert S; Kristiansen G; Schwamborn K; Gassler N; Knuechel R; Gaisa NT;
    Virchows Arch; 2020 Sep; 477(3):445-454. PubMed ID: 32198650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study.
    Pires-Luis AS; Martinek P; Alaghehbandan R; Trpkov K; Comperat EM; Perez Montiel DM; Bulimbasic S; Lobo J; Henrique R; Vanecek T; Pivovarcikova K; Michalova K; Pitra T; Hora M; Marques A; Lopes JM; Rogala J; Mareckova J; Michal M; Hes O
    Adv Anat Pathol; 2020 Sep; 27(5):303-310. PubMed ID: 32520749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-type poorly differentiated adenocarcinoma of the stomach: clinicopathological and molecular characteristics and histogenesis.
    Arai T; Matsuda Y; Aida J; Takubo K; Ishiwata T
    Gastric Cancer; 2019 Mar; 22(2):314-322. PubMed ID: 30088163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.
    Zaleski MP; Chen H; Roy-Chowdhuri S; Patel KP; Luthra R; Routbort MJ; Kamat AM; Gao J; Siefker-Radtke A; Czerniak B; Guo CC
    Am J Clin Pathol; 2022 Aug; 158(2):263-269. PubMed ID: 35467000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of microsatellite instability and its substantial co-existence with
    Nguyen HT; Le DT; Duong QH; Tatipamula VB; Van Nguyen B
    Oncol Lett; 2021 Jan; 21(1):41. PubMed ID: 33262833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
    Riva G; Mian C; Luchini C; Girolami I; Ghimenton C; Cima L; Novelli L; Hanspeter E; Mazzoleni G; Schwienbacher C; Pycha S; D'Elia C; Trenti E; Pycha A; Martignoni G; Hes O; Eccher A; Nesi G; Brunelli M
    Virchows Arch; 2019 Jan; 474(1):13-20. PubMed ID: 30302546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.